Funds holding Kalaris Therapeutics Inc
ISIN US4829291065 · United States
- Fund holders
- 19
- Of which ETFs
- 3 16 other funds
- Value held
- 2.3M $
- Share of capital
- 2.3 % of 23.8M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 255,337 | 1M $ | 1.07 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 137,373 | 559.1K $ | 0.00 % | 0.58 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 34,574 | 182.2K $ | 0.00 % | 0.15 % | as of May 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 32,500 | 132.3K $ | 0.09 % | 0.14 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 25,924 | 105.5K $ | 0.01 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 16,829 | 88.7K $ | 0.00 % | 0.07 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 9,885 | 52.1K $ | 0.04 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,575 | 50.5K $ | 0.04 % | as of May 31, 2026 ↗ | |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 8,020 | 32.6K $ | 0.00 % | 0.03 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 7,806 | 31.8K $ | 0.00 % | 0.03 % | as of Jun 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 6,002 | 24.4K $ | 0.03 % | as of Jun 30, 2026 ↗ | |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,296 | 11.6K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 2,750 | 9.7K $ | 0.00 % | 0.01 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 2,614 | 9.2K $ | 0.01 % | as of Jul 31, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 1,725 | 7K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 911 | 3.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 135 | 549.5 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 79 | 321.5 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 47 | 165 $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.09 % | as of Jun 30, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.00 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 19 | +3 | 555,382 | +20.6 % |
| 2026Q2 | 16 | +1 | 460,626 | +16.5 % |
| 2026Q1 | 15 | +1 | 395,353 | +49.8 % |
| 2025Q4 | 14 | 0 | 263,871 | +45.5 % |
| 2025Q3 | 14 | +5 | 181,386 | +44.7 % |
| 2025Q2 | 9 | 125,361 |
Institutional managers
55 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 12,948,081 | 74.7M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,300,000 | 7.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 700,000 | 4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 572,687 | 3.3M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 435,798 | 2.5M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 360,000 | 2.1M $ | as of Mar 31, 2026 |
| Propel Bio Management, LLC | 295,771 | 1.7M $ | as of Mar 31, 2026 |
| Kalehua Capital Management LLC | 135,585 | 782.3K $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 118,887 | 686K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 110,503 | 637.6K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 100,000 | 577K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 100,000 | 577K $ | as of Mar 31, 2026 |
| WHI TRUST Co LLC | 97,493 | 562.5K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 92,261 | 532.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 87,545 | 505.3K $ | as of Mar 31, 2026 |
| Simplify Asset Management Inc. | 87,426 | 504.4K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 67,879 | 391.7K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 66,151 | 381.7K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 59,534 | 343.5K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 52,684 | 304K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 45,000 | 259.7K $ | as of Mar 31, 2026 |
| Belpointe Asset Management LLC | 40,000 | 230.8K $ | as of Mar 31, 2026 |
| Fortis Capital Advisors, LLC | 40,000 | 230.8K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 39,773 | 229.5K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 38,344 | 221.2K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Kalaris Therapeutics Inc". https://titelia.com/en/stocks/kalaris-therapeutics-inc-US4829291065